[go: up one dir, main page]

DE60309349D1 - Propanamine derivate als serotonin und norepinephrin reuptake-inhibitoren - Google Patents

Propanamine derivate als serotonin und norepinephrin reuptake-inhibitoren

Info

Publication number
DE60309349D1
DE60309349D1 DE60309349T DE60309349T DE60309349D1 DE 60309349 D1 DE60309349 D1 DE 60309349D1 DE 60309349 T DE60309349 T DE 60309349T DE 60309349 T DE60309349 T DE 60309349T DE 60309349 D1 DE60309349 D1 DE 60309349D1
Authority
DE
Germany
Prior art keywords
sub
alkyl
halo
substituents
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60309349T
Other languages
English (en)
Other versions
DE60309349T2 (de
Inventor
Louis Boulet
Ann Filla
Peter Gallagher
John Hudziak
Margareta Johansson
E Karanjawala
Joseph Masters
Victor Graffinity Matassa
Michael Mathes
Richard Rathmell
Maria Whatton
Nolan Wolfe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE60309349D1 publication Critical patent/DE60309349D1/de
Publication of DE60309349T2 publication Critical patent/DE60309349T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60309349T 2002-11-05 2003-10-24 Propanamine derivate als serotonin und norepinephrin reuptake-inhibitoren Expired - Fee Related DE60309349T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42412602P 2002-11-05 2002-11-05
US424126P 2002-11-05
PCT/US2003/031512 WO2004043931A1 (en) 2002-11-05 2003-10-24 Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors

Publications (2)

Publication Number Publication Date
DE60309349D1 true DE60309349D1 (de) 2006-12-07
DE60309349T2 DE60309349T2 (de) 2007-05-10

Family

ID=32312755

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60309349T Expired - Fee Related DE60309349T2 (de) 2002-11-05 2003-10-24 Propanamine derivate als serotonin und norepinephrin reuptake-inhibitoren

Country Status (7)

Country Link
US (1) US7410982B2 (de)
EP (1) EP1567501B1 (de)
AT (1) ATE343566T1 (de)
AU (1) AU2003287022A1 (de)
DE (1) DE60309349T2 (de)
ES (1) ES2274286T3 (de)
WO (1) WO2004043931A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7410996B2 (en) 2002-11-05 2008-08-12 Eli Lilly And Company 3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake
AU2003287024A1 (en) 2002-11-05 2004-06-03 Eli Lilly And Company 3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norephinephrine reuptake
US20050008607A1 (en) * 2003-06-05 2005-01-13 L'oreal Composition containing a carbonyl amine
EP1789050A1 (de) * 2004-08-09 2007-05-30 Warner-Lambert Company LLC Neue chinoxalinon-norepinephrin-wiederaufnahmehemmer zur behandlung von erkrankungen des zentralnervensystems
EP1786778A1 (de) * 2004-08-26 2007-05-23 Neurosearch A/S Neue substituierte heteroaryloxyalkylamine und deren verwendung als monoamin neurotransmitter wiederaufnahmehemmer
US8690831B2 (en) * 2008-04-25 2014-04-08 Ethicon Endo-Surgery, Inc. Gas jet fluid removal in a trocar
US20100051879A1 (en) * 2006-11-22 2010-03-04 The Regents od the Univesity of California Functionalized Boron Nitride Nanotubes
WO2008150528A1 (en) * 2007-06-04 2008-12-11 Intra-Cellular Therapies, Inc. Novel methods
US8101642B2 (en) 2008-06-05 2012-01-24 Sk Biopharmaceuticals Co., Ltd. 3-substituted propanamine compounds
EP3339307A1 (de) * 2016-12-20 2018-06-27 Laboratorios del Dr. Esteve, S.A. Stickstoffhaltige bicyclische derivate zur behandlung von schmerzen und schmerzbedingten leiden
EP3339304A1 (de) 2016-12-20 2018-06-27 Laboratorios del Dr. Esteve, S.A. Neue chinolin- und isochinolinderivate zur behandlung von schmerzen und schmerzbedingten leiden
CN113214182B (zh) * 2021-05-19 2022-12-23 佛山湘潭大学绿色智造研究院 一种苯并异噻唑类化合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2060622B (en) 1979-09-14 1983-05-25 Wyeth John & Brother Ltd 3-aryl-3-aryloxyalkylamines
US4956388A (en) * 1986-12-22 1990-09-11 Eli Lilly And Company 3-aryloxy-3-substituted propanamines
US4902710A (en) 1988-12-14 1990-02-20 Eli Lilly And Company Serotonin and norepinephrine uptake inhibitors
GB0112122D0 (en) 2001-05-18 2001-07-11 Lilly Co Eli Heteroaryloxy 3-substituted propanamines
AU2003287024A1 (en) 2002-11-05 2004-06-03 Eli Lilly And Company 3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norephinephrine reuptake

Also Published As

Publication number Publication date
EP1567501B1 (de) 2006-10-25
DE60309349T2 (de) 2007-05-10
US20060058360A1 (en) 2006-03-16
WO2004043931A1 (en) 2004-05-27
EP1567501A1 (de) 2005-08-31
US7410982B2 (en) 2008-08-12
AU2003287022A1 (en) 2004-06-03
ATE343566T1 (de) 2006-11-15
ES2274286T3 (es) 2007-05-16

Similar Documents

Publication Publication Date Title
ATE309801T1 (de) Heteroaryloxy 3-substituierte propanamine s serotonin und norepinephrin reuptake-inhibitoren
SU1470183A3 (ru) Способ получени амидных производных хинолина или их солей присоединени кислоты
DE60309349D1 (de) Propanamine derivate als serotonin und norepinephrin reuptake-inhibitoren
CY1107221T1 (el) Παραγωγα τριαζολιου ως ανταγωνιστες υποδοχεα ταχυκινινης
AR057023A1 (es) Compuestos heterociclicos con propiedades inhibidoras de hiv-integrasa
BRPI0606806A2 (pt) compostos indólicos, suas composições e seus usos
DE69835760D1 (de) Inhibitoren der cetp-aktivität
DE69918404D1 (de) Aminophenoxyessigsäure derivate als neuroschützende mittel
NO20064297L (no) Aminoalkoholforbindelse
ATE356624T1 (de) Phenoxypropanolamin-derivate, ihre herstellung und therapeutische verwendung
WO2008145839A8 (fr) Dérivés de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur préparation et leur application en thérapeutique
BR0313846A (pt) Derivados de dioxano-2-alquilcarbamatos, sua preparação e sua aplicação em terapêutica
ATE413882T1 (de) 2-(phenylthiomethyl)- morpholin-derivate zur verwendung als selektive norepinephrin- wiederaufnahme-inhibitoren
CA2521732A1 (en) Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
RU2012106822A (ru) Индольное производное или его фармацевтически приемлемая соль
PL378201A1 (pl) Sposób farmaceutyczny oraz związki wytwarzane tym sposobem
EA200401519A1 (ru) N- ациламинобензольные производные в качестве селективных ингибиторов моноаминооксидазы b
ATE374750T1 (de) Serotoninwiederaufnahme-inhibitoren
MY143245A (en) 4- 2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases
HRP20030610B1 (en) Process for the preparation of mesylates of piperazine derivatives
EA200200523A1 (ru) Новые разветвленные замещенные аминопроизводные 3-амино-1-фенил-1h[1,2,4]триазола, способы их получения и содержащие их фармацевтические композиции
BR0013075A (pt) Derivados de tetrazolinona
ATE445619T1 (de) Pyridinylpyrazolopyrimidinon-derivate als pde 7 inhibitoren
DK0640612T3 (da) Hidtil ukendte derivater af 2-(1H)-quinolinon, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdend
RU2003132456A (ru) Производные арил(или гетероарил)азолилкарбинола для лечения респираторных заболеваний

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8339 Ceased/non-payment of the annual fee